Literature DB >> 14970260

The 12 kDa FK506-binding protein, FKBP12, modulates the Ca(2+)-flux properties of the type-3 ryanodine receptor.

Kristel Van Acker1, Geert Bultynck, Daniela Rossi, Vincenzo Sorrentino, Noel Boens, Ludwig Missiaen, Humbert De Smedt, Jan B Parys, Geert Callewaert.   

Abstract

We have characterised the functional regulation of the type-3 ryanodine receptor by the 12 kDa FK506-binding protein. Wild-type type-3 ryanodine receptor and mutant type-3 ryanodine receptor in which the critical valine at position 2322 in the central 12 kDa FK506-binding protein binding site was substituted by aspartate, were stably expressed in human embryonic kidney cells. In contrast to the wild-type receptor, the mutant receptor was strongly impaired in binding to immobilised glutathione S-transferase 12 kDa FK506-binding protein. Caffeine-induced 45Ca(2+)-efflux was markedly increased in cells expressing mutant type-3 ryanodine receptor whereas the maximal-releasable Ca2+ was not affected. Confocal Ca2+ imaging provided clear evidence for a much higher sensitivity of the mutant receptor, which showed global Ca2+ release at about 20-fold lower caffeine concentrations than the wild-type receptor. Spontaneous Ca2+ sparks were observed in both wild-type- and mutant-expressing cells but the number of sparking cells was about 1.5-fold higher in the mutant group, suggesting that the degree of FK506 binding controls the stability of the closed state of ryanodine receptor channels. Furthermore, overexpression of 12 kDa FK506-binding protein decreased the number of sparking cells in the wild-type-expressing cells whereas it did not affect the number of sparking cells in cells expressing the mutant receptor. Concerning spark properties, the amplitude and duration of Ca2+ sparks mediated by mutant channels were significantly reduced in comparison to wild-type channels. This suggests that functional coupling between different mutant type-3 ryanodine receptor channels in a cluster is impaired. Our findings show for the first time that the central binding site for the 12 kDa FK506-binding protein of type-3 ryanodine receptor, encompassing the critical valine proline motif, plays a crucial role in the modulation of the Ca2+ release properties of the type-3 ryanodine receptor channel, including the regulation of both global Ca2+ responses and spontaneous Ca2+ sparks.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14970260     DOI: 10.1242/jcs.00948

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  9 in total

1.  FK506-binding protein 12 modulates μ-opioid receptor phosphorylation and protein kinase C(ε)-dependent signaling by its direct interaction with the receptor.

Authors:  Yu Qiu; Wei Zhao; Yan Wang; Jian-Rong Xu; Eddie Huie; Shan Jiang; Ying-Hui Yan; Horace H Loh; Hong-Zhuan Chen; Ping-Yee Law
Journal:  Mol Pharmacol       Date:  2013-10-10       Impact factor: 4.436

2.  RYR3 gene variants in subclinical atherosclerosis among HIV-infected women in the Women's Interagency HIV Study (WIHS).

Authors:  Aditi Shendre; Marguerite R Irvin; Bradley E Aouizerat; Howard W Wiener; Ana I Vazquez; Kathryn Anastos; Jason Lazar; Chenglong Liu; Roksana Karim; Nita A Limdi; Mardge H Cohen; Elizabeth T Golub; Degui Zhi; Robert C Kaplan; Sadeep Shrestha
Journal:  Atherosclerosis       Date:  2014-01-30       Impact factor: 5.162

Review 3.  Unraveling the role of peptidyl-prolyl isomerases in neurodegeneration.

Authors:  Melanie Gerard; Angélique Deleersnijder; Jonas Demeulemeester; Zeger Debyser; Veerle Baekelandt
Journal:  Mol Neurobiol       Date:  2011-05-07       Impact factor: 5.590

4.  Enantiomeric specificity of (-)-2,2',3,3',6,6'-hexachlorobiphenyl toward ryanodine receptor types 1 and 2.

Authors:  Isaac N Pessah; Hans-Joachim Lehmler; Larry W Robertson; Claudio F Perez; Elaine Cabrales; Diptiman D Bose; Wei Feng
Journal:  Chem Res Toxicol       Date:  2009-01       Impact factor: 3.739

5.  Ryanodine receptor allosteric coupling and the dynamics of calcium sparks.

Authors:  Jeffrey R Groff; Gregory D Smith
Journal:  Biophys J       Date:  2008-03-21       Impact factor: 4.033

6.  Removal of FKBP12 enhances mTOR-Raptor interactions, LTP, memory, and perseverative/repetitive behavior.

Authors:  Charles A Hoeffer; Wei Tang; Helen Wong; Arturo Santillan; Richard J Patterson; Luis A Martinez; Maria V Tejada-Simon; Richard Paylor; Susan L Hamilton; Eric Klann
Journal:  Neuron       Date:  2008-12-10       Impact factor: 17.173

Review 7.  Ryanodine receptor-mediated arrhythmias and sudden cardiac death.

Authors:  Lynda M Blayney; F Anthony Lai
Journal:  Pharmacol Ther       Date:  2009-04-01       Impact factor: 12.310

8.  Unbound Plasma, Total Plasma, and Whole-Blood Tacrolimus Pharmacokinetics Early After Thoracic Organ Transplantation.

Authors:  Maaike A Sikma; Erik M Van Maarseveen; Claudine C Hunault; Javier M Moreno; Ed A Van de Graaf; Johannes H Kirkels; Marianne C Verhaar; Jan C Grutters; Jozef Kesecioglu; Dylan W De Lange; Alwin D R Huitema
Journal:  Clin Pharmacokinet       Date:  2020-06       Impact factor: 6.447

9.  Transcriptomic and proteomic analyses of rhabdomyosarcoma cells reveal differential cellular gene expression in response to enterovirus 71 infection.

Authors:  Wai Fook Leong; Vincent T K Chow
Journal:  Cell Microbiol       Date:  2006-04       Impact factor: 3.715

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.